본문으로 건너뛰기
← 뒤로

Mechanisms of T cell-mediated immune evasion in cervical cancer: a comprehensive bibliometric analysis and future research directions.

Immunological medicine 2026 Vol.49(1) p. 1-21

Bai X, Wang H, Guo Q

📝 환자 설명용 한 줄

Cervical cancer, a prevalent malignancy caused by high-risk HPV strains, remains a significant challenge due to its ability to evade the immune system, particularly T cell-mediated responses.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Bai X, Wang H, Guo Q (2026). Mechanisms of T cell-mediated immune evasion in cervical cancer: a comprehensive bibliometric analysis and future research directions.. Immunological medicine, 49(1), 1-21. https://doi.org/10.1080/25785826.2025.2560214
MLA Bai X, et al.. "Mechanisms of T cell-mediated immune evasion in cervical cancer: a comprehensive bibliometric analysis and future research directions.." Immunological medicine, vol. 49, no. 1, 2026, pp. 1-21.
PMID 40970674

Abstract

Cervical cancer, a prevalent malignancy caused by high-risk HPV strains, remains a significant challenge due to its ability to evade the immune system, particularly T cell-mediated responses. This study aims to explore the research landscape surrounding T cell-mediated immune evasion in cervical cancer through a comprehensive bibliometric analysis. Using data from the Web of Science Core Collection (2014-2023), we employed VOSviewer, CiteSpace, and the R package "bibliometrics" to conduct co-citation and co-occurrence analyses, identifying key trends, contributors, and research hotspots. Our analysis included 930 studies from 68 countries, with China, the USA, and the Netherlands as the leading contributors. Emerging topics include immune checkpoint inhibitors, PD-L1, and tumor microenvironment modulation, highlighting the growing focus on immune-based therapies. This study provides valuable insights into the role of T cells in cervical cancer progression and offers a foundation for future research directions aimed at improving immunotherapy outcomes in cervical cancer patients.

MeSH Terms

Humans; Uterine Cervical Neoplasms; Female; Bibliometrics; T-Lymphocytes; Tumor Microenvironment; Tumor Escape; Immunotherapy; Immune Evasion; Immune Checkpoint Inhibitors

같은 제1저자의 인용 많은 논문 (5)